|
Alpelisib 300 mg Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since August 2026
Also known as: Piqray
Pipeline
Phase 1: 2
Top Sponsors
- Columbia University2
Indications
- Diabetes2
- Insulin Resistance2
- Healthy Adult Participants1
- Liver Disease1
- Prediabetic State1
New York, New York2 trials
Alpelisib Challenge Test (ACT)
Columbia University Irving Medical Center
Phase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University Irving Medical Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.